This may be particularly appropriate in patients with more severe asthma in whom corticosteroids are less effective as there may be a reduction in HDAC activity in these patients [37] as well as in smoking asthmatics patients [109] and patients with COPD [114]. The gene discussed is HDAC9; the disease is chronic obstructive pulmonary disease.